Success Metrics

Clinical Success Rate
70.0%

Based on 7 completed trials

Completion Rate
70%(7/10)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
3(27%)

Phase Distribution

Ph phase_1
1
9%
Ph phase_3
4
36%
Ph not_applicable
3
27%
Ph early_phase_1
1
9%
Ph phase_2
2
18%

Phase Distribution

2

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
4(36.4%)
N/ANon-phased studies
3(27.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(7)
Terminated(3)
Other(1)

Detailed Status

Completed7
Terminated3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
70.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (9.1%)
Phase 11 (9.1%)
Phase 22 (18.2%)
Phase 34 (36.4%)
N/A3 (27.3%)

Trials by Status

completed764%
terminated327%
unknown19%

Recent Activity

0 active trials
Showing 5 of 11
completednot_applicable

Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum

NCT01588171
completednot_applicable

Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries

NCT01630148
terminatedphase_2

Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19

NCT04420299
completedearly_phase_1

Low Molecular Weight Heparin in Pregnancies With Unexplained Stillbirths

NCT03601338
unknownphase_3

Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients

NCT02802605
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT01588171Not Applicable

Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum

Completed
NCT01630148Not Applicable

Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries

Completed
NCT04420299Phase 2

Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19

Terminated
NCT03601338Early Phase 1

Low Molecular Weight Heparin in Pregnancies With Unexplained Stillbirths

Completed
NCT02802605Phase 3

Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients

Unknown
NCT02795065Not Applicable

Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients

Completed
NCT00311896Phase 3

Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT)

Terminated
NCT00324558Phase 2

Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)

Terminated
NCT00413088Phase 1

Study to Assess Bemiparin Pharmacokinetics in Renal Insufficiency and in the Elderly

Completed
NCT00448903Phase 3

Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers

Completed
NCT00219973Phase 3

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11